Citations

Mayo Clinic

Clear

70 citation(s) found for "Wa, Oldenburg".

Occupational Therapy Practitioners’ Perceptions on Addressing Cognition in Acute Care: A National Survey
Friend, Payton , Trenary, Tamra , Oldenburg, Hannah

Occupational Therapy In Health Care | February 24, 2024 | Volume: 39 | Issue: 2 | Pages: 376-396

10.1080/07380577.2024.2315487 | PMID 38400567 Get It

What students say to be ready for acute care: Implications for preceptors
Oldenburg, Hannah , Hake, Melissa P. , Rindflesch, Aaron , Hake, Melissa , Oldenburg, Hannah , Rindflesch, Aaron B

The Clinical Teacher | August 31, 2023 | Volume: 21 | Issue: 1 | Pages: No page available

10.1111/tct.13638 | PMID 37650458 Get It

Abstract Background Student readiness for clinical education experiences is an important variable for clinical preceptors. Readiness has been reported from the viewpoints of clinicians, academic faculty, clinical preceptors, employers and novice graduate physical therapists. Perspectives from physical and occupational therapy students could better prepare preceptors in the acute care setting. Approach Thematic analysis was conducted following the approach described by Braun and Clarke. The purpose of this study was to describe physical and occupational therapy student perceptions of readiness for full‐time acute care clinical education experiences. Twenty‐one physical and occupational therapy students in process of completing full‐time clinical education experiences at a large academic medical centre were qualitatively interviewed in small groups. A two‐stage iterative process of thematic inquiry was used to induce themes about student readiness for full‐time acute care clinical experiences. Transcription, coding and thematic analysis were completed. Students also completed a one‐time questionnaire with demographic and learner characteristic scales. Findings Participants were on average 26.4 years old, predominantly female and White, and had completed one full‐time clinical education experience prior to participation. Four major thematic categories of student readiness for acute care clinical experiences emerged: (1) mindset and willingness; (2) knowledge and experience; (3) communication and collaboration; and (4) planning and prioritising. Implications Students report their readiness is facilitated by preceptors who can model flexibility, foster communication that promotes clinical reasoning, implement an orientation to the acute care culture and learning resources and scaffold roles and responsibilities to aid professional authority.
Acute type A aortic dissection in adolescents and young adults under 30 years of age: demographics, aetiology and postoperative outcomes of 139 cases
Luehr, Maximilian , Yıldız, Murat , Ma, Wei‐Guo , Heck, Roland , Polycarpou, Andreas , Jassar, Arminder S. , Weiss, Gabriel , Hagl, Christian, Rega, Filip , Schachner, Thomas , Martens, Andreas , Corte, Alessandro Della , Osada, Hiroaki, Sun, Lizhong, Tsagakis, Konstantinos , Schoenhoff, Florian , Sun, Li-Zhong , Weiss, Gabriel , Schachner, Thomas , Martens, Andreas , Della Corte, Alessandro , Sun, Li-Zhong , Tsagakis, Konstantinos , Schoenhoff, Florian , Kreibich, Maximilian , Dohle, Daniel‐Sebastian

European Journal of Cardio-Thoracic Surgery | March 23, 2023 | Volume: 63 | Issue: 5 | Pages: No page available

10.1093/ejcts/ezad112 | PMID 36951534 Get It

Abstract OBJECTIVES The prevalence and aetiology of acute aortic dissection type A (AADA) in patients ≤30 years is unknown. The aims of this clinical study were to determine the prevalence and potential aetiology of AADA in surgically treated patients ≤30 years and to evaluate the respective postoperative outcomes in this selective group of patients in a large multicentre study. METHODS Retrospective data collection was performed at 16 participating international aortic institutions. All patients ≤30 years at the time of dissection onset were included. The postoperative results were analysed with regard to connective tissue disease (CTD). RESULTS The overall prevalence of AADA ≤30 years was 1.8% (139 out of 7914 patients), including 51 (36.7%) patients who were retrospectively diagnosed with CTD. Cumulative postoperative mortality was 8.6%, 2.2% and 1.4%. Actuarial survival was 80% at 10 years postoperatively. Non-CTD patients (n = 88) had a significantly higher incidence of arterial hypertension (46.6% vs 9.8%; P < 0.001) while AADA affected the aortic root (P < 0.001) and arch (P = 0.029) significantly more often in the CTD group. A positive family history of aortic disease was present in 9.4% of the study cohort (n = 13). CONCLUSIONS The prevalence of AADA in surgically treated patients ≤30 years is <2% with CTD and arterial hypertension as the 2 most prevalent triggers of AADA. Open surgery may be performed with good early results and excellent mid- to long-term outcomes.
Association of abnormal p‐wave parameters with brain MRI morphology: The atherosclerosis risk in communities neurocognitive study (ARIC‐NCS)*
Reyes, Jorge L. , Norby, Faye L. , Ji, Yuekai, Wang, Wendy , Parikh, Romil R , Zhang, Michael J. , Oldenburg, Niki , Lutsey, Pamela L. , Johansen, Michelle C. , Soliman, Elsayed Z. , Alonso, Álvaro , Alonso, Alvaro , Zhang, Michael , Lutsey, Pamela L , Johansen, Michelle C , Parikh, Romil R , Jack, Clifford R. , Gottesman, Rebecca F. , Coresh, Josef , Mosley, Thomas H. , Chen, Lin Y.

Pacing and Clinical Electrophysiology | March 16, 2023 | Volume: 46 | Issue: 8 | Pages: 951-959

10.1111/pace.14687 | PMID 36924350 Get It

AbstractBackgroundRecent evidence indicates that abnormal P‐wave parameters (PWPs)—ECG markers of atrial myopathy—are associated with incident dementia, independent of atrial fibrillation (AF) and clinical ischemic stroke. However, the mechanisms remain unclear and may include subclinical vascular brain injury. Hence, we evaluated the association of abnormal PWPs with brain MRI correlates of vascular brain injury in the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC‐NCS).MethodsARIC‐NCS participants who underwent 3T brain MRI scans in 2011–2013 were included. PWPs were measured from standard 12‐lead ECGs. Brain MRI outcomes included cortical infarcts, lacunar infarcts, cerebral microhemorrhages, brain volumes, and white matter disease (WMD) volume. We used weighted multivariable logistic and linear regression to evaluate the associations of abnormal PWPs with brain MRI outcomes.ResultsAmong 1715 participants (mean age, 76.1 years; 61% women; 29% Black), 797 (46%) had ≥1 abnormal PWP. After multivariable adjustment, including adjusting for prevalent AF, abnormal P‐wave terminal force in lead V1 (aPTFV1) and prolonged P‐wave duration (PPWD) were associated with increased odds of both cortical (OR 1.41; 95% CI, 1.14 to 1.74 and OR 1.30; 95% CI, 1.04 to 1.63, respectively) and lacunar infarcts (OR 1.36; 95% CI, 1.15 to 1.63 and OR 1.37; 95% CI, 1.15 to 1.65, respectively). Advanced interatrial block (aIAB) was associated with higher odds of subcortical microhemorrhage (OR 2.04; 95% CI, 1.36 to 3.06). Other than a significant association between aPTFV1 with lower parietal lobe volume, there were no other significant associations with brain or WMD volume.ConclusionIn this exploratory analysis of a US community‐based cohort, ECG surrogates of atrial myopathy are associated with a higher prevalence of brain infarcts and microhemorrhage, suggesting subclinical vascular brain injury as a possible mechanism underlying the association of atrial myopathy with dementia.
P788 Endoscopic management of patients with high-risk colorectal colitis-associated neoplasia: a Delphi study
Bak, M , Suzuki, Noriko , Matsumoto, Takayuki , Kiesslich, R, Coron, Emmanuel , Vries, Annemarie de , Hart, Adam , Pioche, M, Oldenburg, Bas , Bak, M, Albéniz, Eduardo , East, James E. , Coelho–Prabhu, Nayantara , Saitō, Yutaka , Banerjee, Rupa , Kaminski, Michal Filip , Woude, C. Janneke van der , Bisschops, Raf , Hart, A, Itzkowitz, Steven H. , Moons, Leon M.G.

Journal of Crohn's and Colitis | January 30, 2023 | Volume: 17 | Issue: Supplement_1 | Pages: i920-i921

10.1093/ecco-jcc/jjac190.0918 Get It

Abstract Background Current guidelines recommend endoscopic resection of visible and endoscopically resectable colorectal colitis-associated neoplasia (CAN) in patients with inflammatory bowel disease (IBD). However, patients with high risk CAN are often not amenable to conventional resections techniques and a consensus approach for the endoscopic management of these lesions is presently lacking. This Delphi study aims to reach consensus amongst experts on the endoscopic management of these lesions. Methods A three-round modified Delphi process was conducted to reach consensus amongst worldwide IBD and/or endoscopy experts (n=18) from three continents. Experts were chosen based on the extensive clinical experience with IBD and/or EMR/ESD in patients with IBD, and the authorship on multiple peer-reviewed publications on CAN, the endoscopic resection of CAN and/or EMR/ESD. Consensus was considered if ≥ 75% agreed or disagreed. Quality of evidence was assessed by the criteria of the Cochrane Collaboration group. Results Consensus was reached on all statements (n=14). Experts agreed on a definition for CAN and high-risk CAN (HR-CAN). Consensus was reached on the examination of the colon with enhanced endoscopic imaging prior to resection, the endoscopic resectability of a HR-CAN lesion and endoscopic assessment and standard report of CAN lesions. In addition, experts agreed on type of resections of HR-CAN (< 20mm, >20 mm, with or without good lifting), endoscopic success (technical success and outcomes), histologic assessment and follow-up in HR-CAN. Conclusion This is the first step in developing international consensus-based recommendations for endoscopic management of (HR-)CAN. Although the quality of available evidence was considered low, consensus was reached on several aspects of the management of (HR-)CAN. The present work and proposed standardization might benefit future studies.
Endovascular Treatment as a Bridge to Successful Surgical Revascularization for Chronic Mesenteric Ischemia
Oldenburg, W. Andrew, Paz‐Fumagalli, Ricardo , McKinney, J. Mark , Hakaim, Albert G., Biebl, Matthias

The American Surgeon | November 29, 2022 | Volume: 70 | Issue: 11 | Pages: 994-998

10.1177/000313480407001113 Get It

Chronic mesenteric ischemia (CMI) can be treated with surgical revascularization or with angioplasty and stenting. As experience has been gained, endovascular treatment appears safe and effective in selected patients. Currently, surgical revascularization has better success and patency rates but also a higher short- and midterm mortality and morbidity, especially in patients at high surgical risk. A 72-year-old female with severe respiratory dysfunction presented with CMI resulting in profound malnutrition. Serial percutaneous interventions averted urgent surgery and reversed the mesenteric ischemia. Nine months later, after repeated angioplasty and stenting had failed, elective uncomplicated iliomesenteric bypass, in a medically optimized patient, resolved the ischemia. At an 18-month follow-up, the graft remained widely patent and the patient asymptomatic with a body weight corresponding to her ideal body weight. Compared to surgical revascularization, reocclusion or restenosis occurs more frequently after endovascular treatment of CMI, and reintervention may be necessary. Nevertheless, percutaneous intervention effectively provides relief from mesenteric ischemia and has lower perioperative complication rates compared to surgery in patients at high surgical risk. After initial relief of the CMI, the patient's condition may improve, allowing for more definitive secondary surgical revascularization, if needed.
Changes in Abdominal Aortic Aneurysm Size after Endovascular Repair with Zenith, AneuRx, and Custom-made Stent-Grafts
Neuhauser, Beate, Oldenburg, W. Andrew, Hakaim, Albert G.

The American Surgeon | November 28, 2022 | Volume: 70 | Issue: 7 | Pages: 630-634

10.1177/000313480407000714 Get It

The aim of this study was to determine the maximal aneurysm diameter (MAD), the total aneurysm volume (TAV), the intra-aneurysm vascular channel (IAVC), and total thrombus volume (TTV) and compare changes in those parameters during a 12-month time period. In addition, these parameters for three different endovascular grafts were compared. A retrospective review of 42 patients who had undergone endovascular aneurysm repair (EVAR) between July 1999 and March 2001, and without evidence of an endoleak or migration, was performed. The minimum follow-up in this group was 12 months. The three grafts deployed were Dacron-stainless steel bifurcated grafts with suprarenal fixation [Zenith; Cook, Inc. ( n = 14)], Dacron stainless steel aorto uni-iliac grafts with suprarenal fixation [custom-made ( n = 10)], and externally supported Dacron nitinol bifurcated grafts [AneuRx; Medtronic, Inc. ( n = 18)]. Volumetric measurements were obtained from CT images performed preoperatively, at 1 month and 12 months thereafter, using a 3-D Magicview 1000 workstation (Siemens, Inc.). Regardless of the type of endograft, a significant Change in MAD and TAV ( P = 0.008), IAVC ( P = 0.031), and TTV ( P = 0.001) was observed over the 12-month postoperative period. Both maximum diameter and total aneurysm volume appear to reflect accurately successful aneurysm exclusion. We conclude that both two-dimensional, maximal aneurysm diameter and three-dimensional, total aneurysm volume accurately reflect changes in morphology after endovascular aneurysm repair.
Larynx proteomics after jellyfish collagen IL: Increased ECM/collagen and suppressed inflammation
Bowen, Andrew J. , Ekbom, Dale C. , Hunter, Danielle E., Voss, Stephen G. , Mearns‐Spragg, Andrew , Oldenburg, Michael , San‐Marina, Serban , Hunter, Danielle, Voss, Stephen , Oldenburg, Michael S , San-Marina, Serban , Bowen, Andrew Jay , Bartemes, Kathleen R.

Laryngoscope Investigative Otolaryngology | September 24, 2022 | Volume: 7 | Issue: 5 | Pages: 1513-1520

10.1002/lio2.924 | PMID 36258863 Get It

AbstractObjectives/HypothesisCompare proteomic profiles of rabbit vocal folds (VFs) injected with micronized cross‐linked jellyfish collagen “collagen Type 0” (MX‐JC) against two clinical products for injection medialization laryngoplasty (IL).Study DesignAnimal model.MethodsLeft recurrent laryngeal nerve sectioning and IL were performed in New Zealand White rabbits (N = 6/group). Group 1 received (MX‐JC) and adipose‐derived stem cells (ADSCs), Group 2, MX‐JC alone; Group 3, cross‐linked hyaluronic acid; and Group 4, micronized acellular dermis. Animals were sacrificed at 4 and 12 weeks. Proteomic profiling of injected versus noninjected VFs by nano‐liquid chromatography, tandem mass spectrometry, and reactome gene ontology analysis was performed.ResultsOverall, 37–61 proteins were found to be upregulated and 60–284 downregulated in injected versus non‐injected VFs (>1.5 fold, false discovery rate‐adjusted p < .05). Over‐representation analysis (% of total) revealed top up‐regulated pathways at 4 and 12 weeks, respectively: Group 1, keratan sulfate metabolism (46%) and cellular processes (29%); Group 2, extracellular matrix (ECM)/collagen processes (33%) and beta oxidation (39%); Group 3, cellular processes (50%) and energy metabolism (100%); and Group 4, keratan sulfate metabolism (31%) and inflammation (50%). Top downregulated pathways were: Group 1, Inflammation (36%) and glucose/citric acid metabolism (42%); Group 2, cell signaling (38%) and glucose/citric acid metabolism (35%); Group 3, keratan sulfate metabolism (31%) and ECM/collagen processes (48%); and Group 4, glucose/citric acid metabolism (33%) and ECM/collagen processes (43%).ConclusionsMX‐JC “collagen Type 0” upregulates pathways related to ECM/collagen formation and downregulates pathways related to inflammation suggesting that it is promising biomaterial for IL.Level of EvidenceNA
Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group
Hoffman, Lindsey M. , Mankad, Kshitij , Kline, Cassie , Ramasubramanian, Aparna , Mangum, Ross , Horne, Vincent E. , Keole, Sameer R., Grosshans, David R. , Packer, Roger J. , Cavalheiro, Sérgio , Hankinson, Todd C. , Warren, Katherine E , Chintagumpala, Murali , Tinkle, Christopher L , Keole, Sameer , Bartels, Ute , Warren, Katherine E , Mangum, Ross , Jaimes, Camilo E. , Mirsky, David M. , Tamrazi, Benita , Malbari, Fatema , Lindsay, Holly , Daniels, David J. , Poussaint, Tina Young , Bison, Brigitte , Muller, Hermann Lothar , Bartels, Ute

Neuro-Oncology | September 15, 2022 | Volume: 25 | Issue: 2 | Pages: 224-233

10.1093/neuonc/noac221 | PMID 36124689 Get It

Abstract Background Craniopharyngioma is a histologically benign tumor of the suprasellar region for which survival is excellent but quality of life is often poor secondary to functional deficits from tumor and treatment. Standard therapy consists of maximal safe resection with or without radiation therapy. Few prospective trials have been performed, and response assessment has not been standardized. Methods The Response Assessment in Pediatric Neuro-Oncology (RAPNO) committee devised consensus guidelines to assess craniopharyngioma response prospectively. Results Magnetic resonance imaging is the recommended radiologic modality for baseline and follow-up assessments. Radiologic response is defined by 2-dimensional measurements of both solid and cystic tumor components. In certain clinical contexts, response to solid and cystic disease may be differentially considered based on their unique natural histories and responses to treatment. Importantly, the committee incorporated functional endpoints related to neuro-endocrine and visual assessments into craniopharyngioma response definitions. In most circumstances, the cystic disease should be considered progressive only if growth is associated with acute, new-onset or progressive functional impairment. Conclusions Craniopharyngioma is a common pediatric central nervous system tumor for which standardized response parameters have not been defined. A RAPNO committee devised guidelines for craniopharyngioma assessment to uniformly define response in future prospective trials.